Literature DB >> 23988499

Association of small foci of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with adenocarcinoma of the lung.

Masoud Mireskandari1, Azita Abdirad, Qing Zhang, Manfred Dietel, Iver Petersen.   

Abstract

DIPNECH is regarded as a precursor lesion of neuroendocrine lung tumors, specifically carcinoids. A relationship with lung adenocarcinomas has not been clearly established so far. We present a series of four cases with a concomitant presence of adenocarcinoma and DIPNECH in the lung. The cases were retrieved from the archives of the Institutes of Pathology of the Jena University Hospital and the Charité, Berlin. The clinical data were collected from the hospital information system. The microscopic findings of adenocarcinoma and DIPNECH were reviewed. A panel of neuroendocrine and epithelial markers was analyzed immunohistochemically. In addition, the H&E slides of a series of 82 lung carcinomas were reevaluated for the presence of DIPNECH foci and the parameters of the IASLC/ATS/ERS classification for lung adenocarcinoma. DIPNECH foci were composed of small intramucosal nests of proliferating pulmonary neuroendocrine cells alongside or at the periphery of terminal airways. All detected foci measured less than 5mm in maximal diameter and showed a consistent reactivity against Synaptophysin. They did not express epithelial markers of squamous cell carcinoma and adenocarcinoma. In three cases, the DIPNECH foci were clearly associated with the adenocarcinoma, while in one case, they were observed in the non-neoplastic lung tissue. The adenocarcinoma with DIPNECH inside mainly showed low grade histology, while the fourth case was intermediate to high grade. The histologic evaluation of the HE slides of the other 82 lung cancer cases showed no suspected or definite DIPNECH foci. Within this series, we could confirm the prognostic significance of the IASLC/ATS/ERS classification of lung adenocarcinoma. Our series suggest that a subset of lung adenocarcinoma is characterized by the concomitant presence of DIPNECH within the tumor, suggesting a causal relationship. These adenocarcinomas seem to be low grade ones, and may have a particular tumorigenesis and clinical behavior. These observations need to be confirmed in larger tumor collectives. We could confirm the prognostic relevance of the new adenocarcinoma classification.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma of lung; Diffuse idiopathic pulmonary neueroendocrine cell hyperplasia (DIPNECH); Grading of lung adenocarcinoma; Lung preneoplasia

Mesh:

Year:  2013        PMID: 23988499     DOI: 10.1016/j.prp.2013.06.019

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

Review 1.  [Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].

Authors:  P A Schnabel; K Junker
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

Review 2.  [Lung cancer. Developments, concepts and preview of the new WHO classification].

Authors:  I Petersen; A Warth
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

3.  DIPNECH: Association Between Histopathology and Clinical Presentation.

Authors:  Rocco Trisolini; Ilaria Valentini; Carmine Tinelli; Marco Ferrari; Gian Marco Guiducci; Sergio Nicola Forti Parri; Giorgia Dalpiaz; Alessandra Cancellieri
Journal:  Lung       Date:  2016-02-15       Impact factor: 2.584

Review 4.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Authors:  Eric Wirtschafter; Ann E Walts; Sandy T Liu; Alberto M Marchevsky
Journal:  Lung       Date:  2015-06-24       Impact factor: 2.584

Review 5.  Lung cancer: developments, concepts, and specific aspects of the new WHO classification.

Authors:  Iver Petersen; Arne Warth
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-22       Impact factor: 4.553

Review 6.  [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].

Authors:  P A Schnabel; K Junker
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

7.  Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria.

Authors:  Olga Sazonova; Venkata Manem; Chloé Béland; Marc-André Hamel; Yves Lacasse; Marie-Hélène Lévesque; Michèle Orain; David Joubert; Steeve Provencher; David Simonyan; Philippe Joubert
Journal:  JTO Clin Res Rep       Date:  2020-07-24

Review 8.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: Case series and a review of the literature.

Authors:  Linfang Jin; Zhiqiang Wang; Xiaowei Qi
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.